Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 31 Aug 2026
- Closes
- 16 Jun 2028, 23:59 UTC
- Reference
- PAR-27-053
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)”. Submissions close on 16 June 2028, 581 days from today. Quote reference PAR-27-053 in any correspondence with the buyer. FreeTender has recorded 459 notices from this buyer since 2023, 368 of them currently open. There are 389 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including fundamental circuitry and behavior relevant to substance use. For projects not requiring a phased research approach, applicants are encouraged to apply under a different funding activity code (e.g., PA-25-305 "Research Project Grant (Parent R01 Clinical Trial Required)" or its subsequent reissue). Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.
CFDA number(s): 93.279
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 459 notices from National Institutes of Health, going back to May 2023 — 368 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 389 open Healthcare & Pharma tenders in United States. This one closes in 581 days.
More from this buyer
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)· closes 1 Feb
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)· closes 17 Feb
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)· closes 10 Oct
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- Tele-Emergency (Tele-Ed) High-Acuity Emergency Support and Telemedicine Sexual Assault Medical Forensic Evaluation support services for Great Plains Area Indian Health Service Units· closes 8 Dec
- Comprehensive Medical Services -FCI Pekin — General Health Care Services· closes 11 Feb
- Suction Apparatus, Surg — 40 each, NSN 6515016775151· closes 19 Nov
- Solicitation - Residential Reentry Center (RRC) Services, Home Confinement (HC) Services - Collin County Texas· closes 11 Jan
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Invitation to Quote for Recalibration Service of Thermohydrograph Instruments and Supply of Compatible Graph Paper and Cartridge PensNational Library Board · Singapore
- Supply of Sample Preparation Reagents for Proteomics AnalysisHome Team Science and Technology Agency · Singapore
- Provision of Registered Inspector (M&E) Consultancy Services for a proposed Polyclinic and Nursing Home at Jurong East Ave 1Ministry of Health-Ministry Headquarter · Singapore
- Provision of Registered Inspector (Architectural) Consultancy Services for a proposed Polyclinic and Nursing Home at Jurong East Ave 1Ministry of Health-Ministry Headquarter · Singapore
- Supply and delivery of Phosphor Plates and Disposable X-ray Barrier envelopes for YPDSHealth Promotion Board · Singapore
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →